Literature DB >> 2297572

Perforin gene expression in granular lymphocyte proliferative disorders.

K Oshimi1, Y Shinkai, K Okumura, Y Oshimi, H Mizoguchi.   

Abstract

By Northern blot analysis using a cDNA clone of the perforin gene, we studied the levels of perforin mRNA in peripheral blood mononuclear cells from 11 cases of granular lymphocyte-proliferative disorders (GLPDs). The granular lymphocytes studied were characterized by morphologic, immunophenotypic, and immunogenotypic analyses. Cytolytic functions of the lymphocytes assayed included nonmajor histocompatibility complex-requiring cytotoxicity, anti-CD3-redirected cytotoxicity, antibody-dependent cellular cytotoxicity, and lectin-dependent cellular cytotoxicity. The results showed that in lymphocytes with strong cytolytic functions high levels of perforin mRNA existed, whereas in lymphocytes with weak or undetectable levels of cytolytic functions, low levels of perforin mRNA existed. Because the levels of perforin mRNA correlated with those of cytolytic functions, perforin is probably a mediator in cytolytic functions of granular lymphocytes in patients with GLPDs. When the lymphocytes were cultured for 1 day, however, the levels of cytolytic activity were increased, and those of perforin mRNA were decreased. Therefore, we cannot rule out the possibility that factors other than perforin protein are involved in the cytolytic functions of granular lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297572

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  How I treat LGL leukemia.

Authors:  Thierry Lamy; Thomas P Loughran
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

Review 2.  The spectrum of large granular lymphocyte leukemia and Felty's syndrome.

Authors:  Xin Liu; Thomas P Loughran
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

3.  Perforin mRNA expression in the inflamed tissues of NZB/W F1 lupus mice decreases with methylprednisolone treatment.

Authors:  T Nakamura; I Ebihara; Y Tomino; K Okumura; H Koide
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

4.  Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.

Authors:  P K Epling-Burnette; J H Liu; R Catlett-Falcone; J Turkson; M Oshiro; R Kothapalli; Y Li; J M Wang; H F Yang-Yen; J Karras; R Jove; T P Loughran
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

5.  Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody.

Authors:  A Hameed; K J Olsen; L Cheng; W M Fox; R H Hruban; E R Podack
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

6.  Angiocentric lymphoma with granulomatous panniculitis in the skin expressing natural killer cell and large granular T-cell phenotypes.

Authors:  M Takeshita; N Kimura; J Suzumiya; K Ohshima; M Kikuchi; R Watanabe; T Okamura; H Goto
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia.

Authors:  Sanjay R Mohan; Michael J Clemente; Manuel Afable; Heather N Cazzolli; Nelli Bejanyan; Marcin W Wlodarski; Alan E Lichtin; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

8.  T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience.

Authors:  Aleksandra Sretenovic; Darko Antic; Snezana Jankovic; Mirjana Gotic; Maja Perunicic-Jovanovic; Ljubomir Jakovic; Biljana Mihaljevic
Journal:  Med Oncol       Date:  2009-03-21       Impact factor: 3.064

9.  Constitutive expression of pore-forming protein in peripheral blood gamma/delta T cells: implication for their cytotoxic role in vivo.

Authors:  M Nakata; M J Smyth; Y Norihisa; A Kawasaki; Y Shinkai; K Okumura; H Yagita
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

Review 10.  Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias.

Authors:  Kazuo Oshimi
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.